A study by Wu et al. demonstrated that mature adipocytes expressing programmed death-ligand 1 (PD-L1) inhibit activation of anti-tumor CD8+ T cells when administered anti-PD-L1 antibody in vitro. The gene discussed is CD8A; the disease is neoplasm.